<DOC>
	<DOCNO>NCT01547000</DOCNO>
	<brief_summary>The goal pilot study obtain preliminary information tolerability efficacy extend release guanfacine ( trade name Intuniv ) child Tourette Disorder ( TD , also call Tourette syndrome ) .</brief_summary>
	<brief_title>Guanfacine Children With Tic Disorders</brief_title>
	<detailed_description>Guanfacine commonly use treatment tic child Tourette Disorder , neither immediate release compound new extended release formulation evaluate tic primary outcome . This pilot study design demonstrate efficacy extend release guanfacine treatment tic child TD . Rather , goal trial determine whether extended release guanfacine warrant study large scale trial . Immediate-release guanfacine frequently use child TD , dose , time effect adverse effect new extended release guanfacine unknown . The use placebo trial reduces bias measurement outcome ensure blindness parent clinician rating . This three-site , investigator-initiated , randomize , double-blind , placebo-controlled , parallel-group study . Subjects show positive response extend release guanfacine 8-week double-blind phase continue drug 8-week extension phase . Subjects randomly assign placebo show improvement offer 8-weeks open-label treatment Intuniv .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Tic Disorders</mesh_term>
	<mesh_term>Tics</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Diagnosis Tourette Disorder chronic motor vocal tic disorder . Between age 6 yr 0 mo 17 year 0 month . Weight &gt; /= 15 kg ( 33 lb ) . Ability swallow pill whole . IQ &lt; 80 . Positive pregnancy test . Positive drug test . Low blood pressure . Prior history hypersensitivity guanfacine . Prior fail treatment adequate trial guanfacine last 2 year . Concurrent treatment another psychoactive medication tic , stimulant medication , Habit Reversal therapy . Medication OCD , anxiety depression allow dose stable 8 wks plan change ; SSRIs allow .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Tourette Syndrome</keyword>
	<keyword>Tourette Disorder</keyword>
	<keyword>Tics</keyword>
	<keyword>Motor tic</keyword>
	<keyword>Vocal tic</keyword>
	<keyword>Intuniv</keyword>
	<keyword>Guanfacine</keyword>
	<keyword>Medication</keyword>
	<keyword>Drug</keyword>
	<keyword>Placebo</keyword>
	<keyword>Child</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescent</keyword>
</DOC>